Figure 7.
Localized intra-tumoral delivery. Isolated AMF (without MP injection) and procedural exposure did not significantly influence tumor or NHP [Fe] nor tumor:NHP ratios as measured by ICP-OES. Direct injection of IO-YAS MPs with magnetic targeting under direct vision yielded a mean tumor:NHP Fe ratio of 75.2 versus 0.77 in the AMF control group (P < 0.05).